Source: Eur Respir J 2006; 28: 1190-1194
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gan C. T., McCann G. P., Marcus J. T., van Wolferen S. A., Twisk J. W., Boonstra A., Postmus P. E., Vonk-Noordegraaf A.. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J 2006; 28: 1190-1194

Member's Comments

No comment yet.

Related content which might interest you: NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension Source: Eur Respir J 2007; 29: 737-744 Year: 2007 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003 MRI assessment of right atrial volume and function in pulmonary hypertension Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation Year: 2012 Right ventricular interaction in pulmonary arterial hypertension Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 The value of tools to assess pulmonary arterial hypertension Source: Eur Respir Rev 2011; 20: 222-235 Year: 2011 Magnetic resonance in pulmonary arterial hypertension: a noninvasive alternative in the assessment of right ventricular function Source: Eur Respir J 2002; 20: Suppl. 38, 4s Year: 2002 The relationship between pro-BNP(brain natriuretic peptide), c-reactive protein(CRP) and right ventricular dysfunction in pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Right ventricular stroke volume measured by MRI as indicator of treatment outcome and predictor of death in patients with pulmonary hypertension Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Determinants of right ventricular diastolic stiffness in precapillary pulmonary hypertension: a cardiac magnetic resonance study Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension Source: Eur Respir J 2009; 33: 1454-1466 Year: 2009 Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007 Connection of traditional echocardiographic and tissue doppler imaging parameters and brain natriuretic peptide levels in patients with different forms of pulmonary hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Tricuspid deceleration time predicts right atrial pressure in patients with suspected pulmonary hypertension: Preliminary experience with cardiac magnetic resonance imaging Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Source: Eur Respir J 2007; 30: 928-936 Year: 2007 Late gadolinium enhancement (LGE), a marker of myocardial damage, can be detected by contrast enhanced-cardiac magnetic resonance imaging within the right ventricle of patients with severe pulmonary hypertension. The extent of LGE relates to RV performanc Source: Eur Respir J 2004; 24: Suppl. 48, 235s Year: 2004